Background

Hepatocyte nuclear factor 4α (HNF4α; NR2A1) is an orphan member of the nuclear receptor superfamily expressed in liver and intestine. While HNF4α expression is critical for liver function, its role in the gut and in the pathogenesis of inflammatory bowel disease (IBD) is unknown.

Methods

Human intestinal biopsies from control and IBD patients were examined for expression of mRNAs encoding HNF4α and other nuclear receptors. An intestine-specific HNF4α null mouse line (Hnf4αΔIEpC) was generated using an Hnf4α-floxed allele and villin-Cre transgene. These mice and their control floxed counterparts (Hnf4αF/F), were subjected to a dextran sulfate sodium (DSS)-induced IBD colitis protocol and their clinical symptoms and gene expression patterns determined.

Results

In human intestinal biopsies, HNF4α was significantly decreased in intestinal tissues from Crohn's disease and ulcerative colitis patients. HNF4α expression was also suppressed in the intestine of DSS-treated mice. In Hnf4αΔIEpC mice, disruption of HNF4α expression was observed in the epithelial cells throughout the intestine. In the DSS-induced colitis model Hnf4αΔIEpC mice showed markedly more severe changes in clinical symptoms and pathologies associated with IBD including loss of body weight, colon length, and histological morphology as compared with Hnf4αF/F mice. Furthermore, the Hnf4αΔIEpC mice demonstrate a significant alteration of mucin-associated genes and increased intestinal permeability, which may play an important role in the increased susceptibility to acute colitis following an inflammatory insult.

Conclusions

While HNF4α does not have a major role in normal function of the intestine, it protects the gut against DSS-induced colitis.

You do not currently have access to this article.